Has Glaxosmi. Pharma declared dividend?
Yes, Glaxosmithkline Pharmaceuticals Ltd has declared a dividend of 420%, with an ex-date of May 30, 2025. The company has shown strong price performance over various periods, with total returns ranging from 39.15% to 161.19% in the last five years.
Glaxosmithkline Pharmaceuticals Ltd has declared a dividend.Dividend Details:
- Percentage announced: 420%
- Ex-date: 30 May 25
Dividend Yield: 0.35%.
Total Returns by Period:
In the last 6 months, the price return was 46.19%, with no dividend return, resulting in a total return of 46.19%.
Over the past year, the price return was 38.7%, with a dividend return of 0.45%, leading to a total return of 39.15%.
In the 2-year period, the price return was 147.26%, with a dividend return of 5.37%, culminating in a total return of 152.63%.
For the 3-year period, the price return was 127.41%, with a dividend return of 9.03%, resulting in a total return of 136.44%.
In the last 4 years, the price return was 127.47%, with a dividend return of 10.87%, leading to a total return of 138.34%.
Over the past 5 years, the price return was 148.51%, with a dividend return of 12.68%, resulting in a total return of 161.19%.
Overall, Glaxosmithkline Pharmaceuticals Ltd has declared a significant dividend, and the total returns over various periods indicate strong price performance, particularly in the longer term, despite relatively modest dividend returns.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
